Facebook
Twitter
LinkedIn
ForwardMiami Neuroscience Institute Neurological Disorders Update
In this course, Diego Torres-Russotto, M.D., discusses the latest, evidence-based treatment of neurological disorders to optimize patient outcomes.
This course includes topics presented at the 11th annual Miami Neuroscience Symposium.
- A Clinician's Approach to Tremors
- Chemodenervation, Dystonia and Spasticity
- Dementia Management
Commercial Supporter
Baptist Health gratefully acknowledges the educational grants provided by Eisai, Merz, Chiesi, Cerenovus, Ipsen Biopharmaceuticals, and Medtronic.
Target Audience
Neurologists, Neurosurgeons, Neuroradiologists, Diagnostic Radiologists, Critical Care Physicians, Neurointensivists, Emergency Medicine Physicians, Internal Medicine Physicians, Interventional Neuroradiologists, Family Physicians, General Internists, Hospitalists, Critical Care and Neuroscience Nurses, Neurosurgery Nurses, Advanced Practice Nurse Practitioners, Physician Assistants, Clinical Neurophysiology Technicians, Pharmacists, Pharmacy Technicians, Rehabilitation and Pain Management Specialists, Occupational Therapists, as well as other specialists interested in the field of neuroscience.
Learning Objectives
A Clinician’s Approach to Tremors
- Implement the movement disorders diagnostic process, including the initial patient interview, examination, likely diagnosis and differential diagnosis.
- Consider the effect that age and phenomenology have on the movement disorders diagnostic process.
- Utilize a tremor algorithm to classify the type of tremor a patient has and select the appropriate therapy.
Chemodenervation, Dystonia and Spasticity
- Differentiate between dystonia and spasticity symptoms.
- Evaluate the clinical presentation of upper motor neuron syndrome and treat the syndrome-related disturbance with a focus on quality of life.
- Involve caregivers in setting post-stroke treatment goals to ensure patient adherence.
- Explain advanced treatment options available for dystonia and spasticity.
Dementia Management
- Identify risk factors and lifestyle factors that increase risk of dementia.
- Accurately stage dementia and implement the appropriate treatment, including non-pharmacological interventions.
- Utilize the DICE – Describe, Investigate, Create, Evaluate – approach to evaluate dementia patients for behavioral and psychological symptoms.
- Evaluate patients on anti-amyloid drugs for ARIA-E and ARIA-H through imaging.
- Apply inclusion criteria for anti-amyloid drugs and communicate with patients and their families about the complexity and time needed for care.
Faculty
Diego Torres-Russotto, M.D.
Chair of Neurology, Chief of Movement Disorders
Neurology Residency Program Director
Miami Neuroscience Institute
Adjunct Professor, Department of Neurological Sciences
University of Nebraska Medical Center
Clinical Professor
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Miami Neuroscience Symposium Planning Committee
Kevin Abrams, M.D.
Chief, Radiology
Medical Director, Neuroradiology and Magnetic Resonance Imaging
Baptist Hospital
Clinical Associate Professor of Radiology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Starlie Belnap, Ph.D.
Clinical Research Supervisor
Miami Neuroscience Institute
Miami, Florida
Nina Cruz, MSN, APRN, FNP-BC, SCRN
Coordinator, Stroke Program
Baptist Hospital
Neuroscience Research
Miami Neuroscience Institute
Miami, Florida
Guilherme Dabus, M.D.
Co-director, Interventional Neuroradiology
Miami Neuroscience Institute
Medical Director, Fellowship Program in Interventional Neuroradiology and Endovascular Neurosurgery
Miami Cardiac & Vascular Institute and Miami Neuroscience Institute
Clinical Professor, Department of Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Felipe De Los Rios La Rosa, M.D., FAHA
Medical Director, Stroke Program
Miami Neuroscience Institute
Miami, Florida
Karel Fuentes, M.D.
Neurointensivist
Baptist, South Miami, Homestead, Doctors and West Kendall Baptist Hospitals
Medical Director, Neurocritical Care
Miami Neuroscience Institute
Clinical Assistant Professor of Neurology
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Italo Linfante, M.D., FAHA
Director, Interventional Neuroradiology
Miami Neuroscience Institute
Clinical Professor of Radiology and Neuroscience
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Michael W. McDermott, M.D., FAANS
Chief Medical Executive
Irma & Kalman Bass Endowed Chair in Clinical Neuroscience
Miami Neuroscience Institute
Chief of the Division of Neuroscience and Professor of Translational Medicine
Florida International University Herbert Wertheim College of Medicine
Miami, Florida
Jamelah Morton, Ph.D., APRN, ACNP-BC, CCRN, CNRN, SCRN
Neurosurgery Advanced Practice Provider Supervisor
Miami Neuroscience Institute
Miami, Florida
Regine Narchet
Seizure and Epilepsy Certificate Holder
Epilepsy Coordinator
Miami Neuroscience Institute
Miami, Florida
Vitaly Siomin, M.D.
Neurosurgeon and Medical Director, Brain Tumor Program
Director, Cerebrovascular Neurosurgery
Co-director, Skull Base Surgery
Miami Neuroscience Institute
Baptist Hospital
Miami, Florida
Justin Sporrer, M.D.
Director, Functional Neurosurgery
Neurosurgeon
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Baptist, Doctors and South Miami Hospitals
Miami, Florida
Ronald Tolchin, D.O.
Physical Medicine and Rehabilitation
Medical Director, Spine Center
Miami Neuroscience Institute
Baptist Health Medical Group
Baptist Health Quality Network
Baptist Hospital
Miami, Florida
The following directors, planners and reviewers have indicated that they do not have any relevant relationships with ineligible companies* to disclose.
Starlie Belnap, Ph.D.
Nina Cruz, MSN, APRN
Karel Fuentes, M.D.
Jamelah Morton, APRN
Regine Narchet, R.N.
Vitaly Siomin, M.D.
Justin Sporrer, M.D.
Ronald Tolchin, D.O.
Disclosures and Resolution of Conflict of Interest
Kevin Abrams, M.D., is a consultant, speaker and shareholder for Viz.AI, and is a shareholder in Cleerly.
Guilherme Dabus, M.D., is a consultant for Cerenovus, InNeuroCo, Medtronic, Microvention, Phenox, Penumbra, Route92, Stryker and Viz.Ai; is a member of the speakers’ bureau for Cerenovus, InNeuroCo, Medtronic, Microvention, Penumbra, Phenox, Route92, Stryker and Viz.Ai; is a stockholder in Cleerly, Hyperion, InNeuroCo, Prometheus Laboratories, Inc., RIST, Synchron, Three Rivers Medical, GHIF and Pireaus; receives research support from SUMMIT MAX; and is a committee member for CREST-2 Interventional Management.
Felipe De Los Rios La Rosa, M.D., is on the speakers’ bureau for AstraZeneca, Andexanet alfa and Brilinta.
Italo Linfante, M.D.,** is a consultant for Q’Apel, Cerenovus, Stryker, Medtronic, Penumbra and Prolong Pharmaceuticals.
Michael McDermott, M.D., is a consultant for Deinde Medical, Stryker, Insightec, ZAP Surgical and Light Helmets.
Diego Torres-Russotto, M.D., is a consultant for AbbVie, Acorda, Ipsen, Neurocrine, Revance, Sunovion, Teva; is on the speakers’ bureau for AbbVie, Acorda, Ipsen, Neurocrine, Teva; and receives grant support from Ipsen, Merz, Revance.
Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies* to disclose.
*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this enduring material for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 2.00 AMA PRA Category 1 Credit™
- 2.00 General certificate of attendance
- 2.00 Nurse Practitioners
- 2.00 Florida Board of Nursing
- 2.00 Florida Board of Occupational Therapy
- 2.00 Florida Board of Pharmacy
Required Hardware/Software
PC/Mac Users
This site is supported on the most recent stable releases of the following browsers:
Google Chrome
Microsoft Edge
Safari
Mozilla Firefox
Mobile Users
This site is supported on the following mobile devices:
- Apple iOS mobile devices running iOS 10 or later
- Android mobile devices running Android 4.4 or later, with the latest release of Google Chrome or Mozilla Firefox
Technical Support
If you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.